169 related articles for article (PubMed ID: 32523375)
1. Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage.
Huang R; Gan Q; Cheng J
Cancer Manag Res; 2020; 12():3445-3456. PubMed ID: 32523375
[TBL] [Abstract][Full Text] [Related]
2. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
[TBL] [Abstract][Full Text] [Related]
3. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry.
Zhou J; Sun JY; Chen SY; Li FY; Lin HX; Wu SG; He ZY
Onco Targets Ther; 2016; 9():67-73. PubMed ID: 26730205
[TBL] [Abstract][Full Text] [Related]
5. Trends and predictors of survival for small cell carcinoma of the cervix uteri: A SEER population study.
Song T; Wan Q; Fang M; Zhan W; Xu H; Shou H
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():35-41. PubMed ID: 32768799
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and outcomes of early-stage small cell neuroendocrine carcinoma of the cervix: 37 cases from a single center.
Zhang D; Ma X
PeerJ; 2019; 7():e6868. PubMed ID: 31110926
[TBL] [Abstract][Full Text] [Related]
8. Small cell carcinoma of the uterine cervix: a multi-institutional experience.
Li J; Ouyang Y; Tao Y; Wang L; Li M; Gao L; Cao X
Int J Gynecol Cancer; 2020 Feb; 30(2):174-180. PubMed ID: 31792086
[TBL] [Abstract][Full Text] [Related]
9. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Analysis and Comparison of the 2014 and 2018 International Federation of Gynecology and Obstetrics Staging System on Overall Survival in Patients with Stage IIB-IVA Cervix Carcinoma.
Song T; Xu H; Shi L; Yan S
Int J Womens Health; 2022; 14():333-344. PubMed ID: 35283649
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
[TBL] [Abstract][Full Text] [Related]
13. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
Li X; Yang R; Jia Y; Zhou J; Ma D; Li S
Int J Gynaecol Obstet; 2015 Jul; 130(1):31-5. PubMed ID: 25890393
[TBL] [Abstract][Full Text] [Related]
14. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.
Liao LM; Zhang X; Ren YF; Sun XY; Di N; Zhou N; Pan RK; Ma SH; Zhou LX
PLoS One; 2012; 7(4):e33674. PubMed ID: 22529895
[TBL] [Abstract][Full Text] [Related]
16. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
17. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix.
Huang L; Lin JX; Yu YH; Zhang MY; Wang HY; Zheng M
PLoS One; 2012; 7(3):e33762. PubMed ID: 22438992
[TBL] [Abstract][Full Text] [Related]
19. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
[TBL] [Abstract][Full Text] [Related]
20. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]